Trial intelligence / Profile preview

Management of Out-of-Range INR in Stable Warfarin Patients

NCT00814177Phase 2Completed

Sponsor
Hamilton Health Sciences
Start
Jul 2006
Primary completion
Jan 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of warfarin in Atrial fibrillation (AFib), venous thromboembolism (VTE), ischemic stroke, myocardial infarction (MI), sponsored by Hamilton Health Sciences. Started Jul 2006; status: completed.

02

Drugs

warfarin
03

Conditions

Atrial fibrillation (AFib)venous thromboembolism (VTE)ischemic strokemyocardial infarction (MI)

Beyond the preview

Go deeper on NCT00814177.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00814177.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call